Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
Select Page
Tesis Biosciences Announces New Test That Can Identify Those in Most Danger from Covid-19

Tesis Biosciences Announces New Test That Can Identify Those in Most Danger from Covid-19

by Xcellerant Ventures | May 11, 2023 | Portfolio Company News

Orgionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-new-test-that-can-identify-those-in-most-danger-from-covid-19-301821712.html PHOENIX, May 11, 2023 /PRNewswire/ — Tesis Biosciences, the leader in targeted genetic...
Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals

by Xcellerant Ventures | Apr 20, 2023 | Portfolio Company News

Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-a-novel-pharmacogenomics-test-enabling-precise-personalized-response-to-wide-range-of-pharmaceuticals-301802763.html PHOENIX, April 20, 2023 /PRNewswire/...
Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury

by Xcellerant Ventures | Dec 9, 2022 | Portfolio Company News

Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-proposed-study-of-veterans-and-civilians-with-mild-traumatic-brain-injury-301698945.html PHOENIX, Dec. 9, 2022 /PRNewswire/ — Tesis Biosciences, the leader...
Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

Tesis Biosciences Acquires Genome Explorations to Accelerate Clinical Research and Product Development for Chronic Disease Cures

by Xcellerant Ventures | Feb 16, 2022 | Portfolio Company News

Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-acquires-genome-explorations-to-accelerate-clinical-research-and-product-development-for-chronic-disease-cures-301483118.html PHOENIX and MEMPHIS, Tenn., Feb. 16,...
John Shufeldt, MD, Joins Tesis Labs Board of Directors

John Shufeldt, MD, Joins Tesis Labs Board of Directors

by Xcellerant Ventures | Oct 13, 2021 | Portfolio Company News

Content origionally from PR News wire: https://www.prnewswire.com/news-releases/john-shufeldt-md-joins-tesis-labs-board-of-directors-301398790.html PHOENIX, Oct. 13, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic sequencing, announced today the...
« Older Entries

Recent Posts

  • AI and Associations – Ethics Statements, Industry Impacts and Planning for the Future
  • Negotiating VC Term Sheets: Fundamentals and Recent Trends
  • TruLite Health Selected as American Hospital Association Equity Transformation Partner
  • TruLite Health Closes $7.0 Million Series A Funding Round Led by Osage Venture Partners
  • AdviNOW mentioned in newly released “2023 Hype Cycle for Digital Care Delivery Including Virtual Care” by Gartner

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023